Oncogene Science was recently acquired by Nuclea
Biotechnologies, Inc. Nuclea is headquartered in Pittsfield, Massachusetts
with additional operations in Worcester, Massachusetts. Nuclea has developed
and is commercializing unique diagnostic tests for colon, breast, leukaemia,
lung and prostate cancer. Nuclea also performs research leading to novel molecular
oncology companion diagnostics for the pharmaceutical and biotechnology industries.
For more information, visit www.nucleabio.com.
with our selection of research use only kits, we strive to provide the medical
community reliable in vitro diagnostics, such as our Serum HER-2/neu
ELISA test, for the monitoring and management of patient care. Please visit
our Products page to learn about our high quality tests for measuring oncogenes,
growth factor receptors (HER-2, EGFr), proteases and protease inhibitors
(uPA, PAI-1, TIMP-1), as well as markers of hypoxia (CA IX).
read: 1 | today: 1